Vanguard Group’s Jaguar Health JAGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5
| Closed | -$60.1K | – | 4293 |
|
|
2024
Q4 | $60.1K | Hold |
5
| – | – | ﹤0.01% | 4200 |
|
|
2024
Q3 | $80.3K | Buy |
5
+4
| +400% | +$95.7K | ﹤0.01% | 4215 |
|
|
2024
Q2 | $37.1K | Buy |
+1
| New | +$109K | ﹤0.01% | 4309 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4404 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4419 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4415 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4479 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4467 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4358 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4384 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 4217 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4291 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4053 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3770 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3289 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3712 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3766 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4105 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4065 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4058 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4079 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4095 |
|
|
2019
Q2 | – | Hold |
0
| – | -$68K | – | 4176 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4040 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4063 |
|
|
2018
Q2 | – | Hold |
0
| – | -$110K | – | 4131 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4021 |
|
|
2017
Q4 | – | Hold |
0
| – | -$25K | – | 4071 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4054 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4009 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3976 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4021 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4028 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4069 |
|
Other funds holding JAGX
Vanguard Group's JAGX Position: Q1 2025 in Review
Vanguard Group sold out of Jaguar Health (JAGX) in Q1 2025, closing a stake of 5 shares — an estimated $60.1K sold.
Vanguard Group first reported a position in JAGX in Q2 2024 and held it in 3 quarters. The position peaked at $80.3K in Q3 2024. 2 funds tracked by Wall St. Rank hold JAGX as of Q1 2025.
- Vanguard Group reported no remaining Jaguar Health position as of Q1 2025 after selling out during the quarter.
- Vanguard Group sold 5 Jaguar Health shares in Q1 2025, an estimated $60.1K.
- Vanguard Group first reported a position in Jaguar Health in Q2 2024 and held it in 3 quarters.
- Vanguard Group's Jaguar Health position peaked at $80.3K in Q3 2024.
- 2 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2025.
Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.